Status:

COMPLETED

Noninvasive Transcutaneous Glucometer Development

Lead Sponsor:

InLight Solutions

Conditions:

Healthy

Prediabetic State (IGT)

Eligibility:

All Genders

18+ years

Brief Summary

The objective of this study is to assist in the development of a noninvasive device for the accurate measurement of blood glucose levels.

Detailed Description

The feasibility of measuring blood glucose concentration in patients with diabetes mellitus using near infrared (NIR) spectroscopy and multivariate data analysis techniques has been established using ...

Eligibility Criteria

Inclusion

  • 18 years of age or older
  • Healthy
  • Type I diabetics
  • Type II diabetics
  • Impaired glucose tolerance

Exclusion

  • Minor status (\<18 years of age)
  • Pregnant

Key Trial Info

Start Date :

December 1 2001

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2008

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT01168076

Start Date

December 1 2001

End Date

December 1 2008

Last Update

July 22 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

InLight Solutions

Albuquerque, New Mexico, United States, 87106

Noninvasive Transcutaneous Glucometer Development | DecenTrialz